Detalhe da pesquisa
1.
Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Blood
; 2023 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720090
2.
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Blood
; 139(15): 2347-2354, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108372
3.
Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia.
Blood
; 137(6): 751-762, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32929488
4.
Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia.
Br J Haematol
; 193(5): 922-927, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161592
5.
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
N Engl J Med
; 378(13): 1189-1199, 2018 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601269
6.
Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients.
Blood
; 133(13): 1457-1464, 2019 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630862
7.
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.
Blood
; 129(12): 1636-1645, 2017 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049642
8.
Basophil-lineage commitment in acute promyelocytic leukemia predicts for severe bleeding after starting therapy.
Mod Pathol
; 31(8): 1318-1331, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572500
9.
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia.
Haematologica
; 102(12): 2039-2047, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971903
10.
The long non-coding RNA Cancer Susceptibility 15 (CASC15) is induced by isocitrate dehydrogenase (IDH) mutations and maintains an immature phenotype in adult acute myeloid leukemia.
Haematologica
; 105(9): e448-453, 2020 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054061
11.
Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK).
Blood
; 120(24): 4706-11, 2012 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047822
12.
CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy.
Br J Haematol
; 180(2): 292-296, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27604396
13.
Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia.
Blood
; 118(23): 6030-6, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21976672
14.
MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice.
Blood
; 118(4): 916-25, 2011 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21628417
15.
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.
J Clin Oncol
; 41(4): 756-765, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315929
16.
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine.
Blood Cancer J
; 13(1): 93, 2023 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37336890
17.
High-dose daunorubicin in older patients with acute myeloid leukemia.
N Engl J Med
; 361(13): 1235-48, 2009 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19776405
18.
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study.
Blood
; 115(13): 2586-91, 2010 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20103782
19.
Non-Invasive Prenatal Testing Leading to Detection of Asymptomatic Acute Myeloid Leukemia in a 30-Year-Old Patient: A Case Report.
J Hematol
; 10(5): 228-231, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34804313
20.
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Blood Adv
; 5(4): 1110-1121, 2021 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33616652